Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immunoprecipitation

Immunoprecipitation

Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...

Protein-Drug Binding: Determination Methods

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An anti-MUC1 antibody-calicheamicin conjugate for treatment of solid tumors. Choice of linker and overcoming drug resistance.

Bioconjugate chemistry·2005

Same author

Scleritodermin A, a cytotoxic cyclic peptide from the lithistid sponge Scleritoderma nodosum.

Journal of natural products·2004

See all related articles

Search research articles

Related Experiment Video

Updated: May 20, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Strategic selection and development of immunogenicity binding methods.

Ana T Menendez¹

¹menendez.bio@gmail.com

|July 17, 2012

Summary

Developing a robust immunogenicity program involves initial binding screens, confirmation, and quantitation. This guide details assay technologies, analytical goals, and validation protocols for reliable drug development.

Area of Science:

Biotechnology
Pharmaceutical Sciences
Drug Development

Background:

Immunogenicity assessment is critical for biologic drug safety and efficacy.
Traditional methods require optimization for diverse drug modalities.
Standardized protocols are essential for regulatory compliance.

Purpose of the Study:

To provide a comprehensive overview of developing a meaningful immunogenicity program.
To guide scientists in selecting appropriate assay technologies and formats.
To outline critical steps for method validation and protocol development.

Main Methods:

Review of evolving immunogenicity technologies and assay formats.
Discussion on selecting assays based on product structure, indication, and pharmacokinetics.

More Related Videos

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Related Experiment Videos

Last Updated: May 20, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Emphasis on feasibility studies, reagent preparation, and robustness testing.

Main Results:

A structured approach to immunogenicity program development is presented.
Guidelines for selecting and optimizing assays based on specific criteria are provided.
Recommendations for ensuring method sensitivity, accuracy, precision, and specificity.

Conclusions:

A well-defined immunogenicity program requires careful planning from initial screening to validation.
The selection of appropriate analytical strategies is paramount for successful drug development.
A checklist for developing a compliant validation protocol is included.